European Pharmaceutical Review

APRIL 16, 2024

Under the terms of the new arrangement, mAbxience will develop and produce the biosimilar product using its expertise in biosimilar development and its current Good Manufacturing Practice (cGMP)-approved facilities located in Spain and Argentina.

Healthcare 80

Healthcare Healthcare Manufacturing Marketing 80

Pharmaceutical Technology

JUNE 28, 2023

Nordic healthcare providers are leading the momentum in enhancing ESG considerations. We examine the regional developments that will provide a competitive edge to pharma manufacturers.

Pharma 52

Pharma Healthcare Provider Competition Manufacturing 52

Clarify Health

OCTOBER 3, 2022

The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. We’re in phase 1 of healthcare’s price transparency movement – internet data dump – but what’s next?

Healthcare 52

Healthcare Healthcare Physicians Insurance 52

Clarify Health

OCTOBER 3, 2022

Recorded Session from the 2022 Consumer Experience & Digital Health Forum The Future of Healthcare’s Price Transparency is Here. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers. “I think the healthcare market is probably very similar.

Healthcare 52

Healthcare Healthcare Physicians Insurance 52

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

Medicine 81

Medicine Healthcare Healthcare Pharma 81

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. They do not have biosimilar or generic competition available in the market.

Manufacturing 111

Manufacturing Competition Marketing Physicians 111

Healthcare Success

JULY 18, 2022

The healthcare industry is constantly evolving, and it’s essential for all healthcare businesses—and their websites—to evolve to stay competitive. Starting around five years ago, we made the strategic decision to refocus our business to serve larger healthcare clients that would benefit most from our expertise.

Healthcare 52

Healthcare Healthcare Competition Marketing 52

World of DTC Marketing

APRIL 12, 2021

Pharmaceutical manufacturers and distributors work together in a robust system to deliver high-quality products, but drug manufacturing and distribution have become increasingly complex in recent years. Outsourcing, which has become mainstream in pharma, has also led to competition that doesn’t always benefit patients.

Food and Drug Administration 187

Food and Drug Administration Prescription Pharma Manufacturing 187

European Pharmaceutical Review

NOVEMBER 30, 2023

The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5

Marketing 99

Marketing Medicine Competition Distribution 99

Eversana Intouch

NOVEMBER 20, 2023

Artificial Intelligence will also facilitate the implementation, interpretation of results and generation of personalized healthcare recommendations. Artificial Intelligence will also facilitate the implementation, interpretation of results and generation of personalized healthcare recommendations.

Marketing 83

Marketing Healthcare Healthcare Pharma 83

PM360

NOVEMBER 27, 2023

In this article, we investigate strategies that manufacturers could consider to optimize pricing and access opportunities for their combinations in today’s environment. This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the U.S. and Europe.

Manufacturing 111

Manufacturing Marketing Competition Patients 111

PM360

JUNE 26, 2023

In 2017, Algeria imposed importation restrictions on medicinal products that could be manufactured domestically, forcing manufacturers to establish local manufacturing facilities or to work with a contract manufacturing organization (CMO). Firstly, entering new markets and increasing sales should boost revenue.

Medicine 98

Medicine Marketing Pharma Manufacturing 98

Healthcare Success

JUNE 6, 2022

Whether you represent a hospital, health system, or multilocation practice, competing healthcare businesses are developing innovative business models—right now—and they’re targeting your market. What’s more, your highest revenue service lines are likely already facing stiff competition from all angles. .

Competition 112

Competition Healthcare Healthcare Marketing 112

European Pharmaceutical Review

JULY 21, 2023

Supporting European biosimilar development Continued investment in biosimilars The planned financing builds on Sandoz’s announced investment in March 2023 of $400 million in a new biologics manufacturing plant in Lendava, Slovenia. This was the largest-ever international private-sector investment in the country, according to the company.

Biopharma 91

Biopharma Manufacturing Competition Healthcare 91

European Pharmaceutical Review

FEBRUARY 6, 2024

Suanfarma has announced a strategic rebranding initiative to reinforce Suanfarma’s position as a global player in the healthcare sector, both as a distributor of active pharmaceutical ingredients (APIs) and as a contract development and manufacturing organisation (CDMO) in the production of APIs.

Manufacturing 80

Manufacturing Distribution Pharmaceutical Competition 80

European Pharmaceutical Review

NOVEMBER 16, 2023

billion by 2032, according to Towards Healthcare. The organisation’s report asserted that growth of the market is being driven by numerous factors including the greater demand for biologics, the expanding biopharmaceutical industry, and the numerous advantages that single-use bioprocessing has over traditional manufacturing methods.

Marketing 77

Marketing Manufacturing Biopharma Competition 77

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Key stumbling blocks include payer activation and reimbursement hurdles, regulatory complexities, tepid market adoption by healthcare professionals (HCPs), field force inefficiencies, and obstacles in engaging and adopting patients.

Biopharma 59

Biopharma Competition Prescription Education 59

Pharma Pathway

SEPTEMBER 23, 2022

Emcure Pharmaceuticals, We are a fast-growing Indian Pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.

Pharmaceutical 80

Pharmaceutical Competition Manufacturing Marketing 80

Pharma Pathway

DECEMBER 1, 2022

Emcure Pharmaceuticals, We are a fast-growing Indian Pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.

Engineering 78

Engineering Pharmaceutical Competition Manufacturing 78

Pharmaceutical Technology

JUNE 30, 2022

will move a step closer to becoming a key healthcare player in Turkey and global markets. Gensenta is a major manufacturer of finished pharmaceuticals and active ingredients in Turkey and is the key producer and exporter of lyophilized vials in the region. s exports and global growth strategy in the field of healthcare.

Pharma 59

Pharma Manufacturing Healthcare Healthcare 59

World of DTC Marketing

FEBRUARY 21, 2022

Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). For less wealthy nations, competition isn’t even a possibility. Reportedly, the cost of production for molnupiravir stands at about $17.74.

Pharma 218

Pharma Competition Manufacturing Medicine 218

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. The increase, from ASP plus 6% to ASP plus 8%, will last for five years, and may help increase access to and utilization of biosimilars and promote competition in the marketplace.

Marketing 97

Marketing Competition Government Manufacturing 97

PM360

SEPTEMBER 28, 2022

healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. With major IRA provisions going into effect over the next few years, it is critical for drug manufacturers to understand and prepare for the implications to their business. The IRA affects several components of the U.S.

Government 97

Government Manufacturing Prescription Competition 97

Salesforce

OCTOBER 21, 2019

You might think that customer relationship management (CRM) software is a solution for sales teams only, but in my experience, CRM can be incredibly valuable to many different teams, especially within the healthcare and life sciences industries. A CRM built for healthcare Twenty years ago, Salesforce pioneered CRM software.

CRM 52

CRM Healthcare Healthcare Customer Relationship Management 52

PM360

SEPTEMBER 21, 2023

Attention deficit hyperactivity disorder (ADHD) drug Vyvanse (lisdexamfetamine dimesylate) , manufactured by Takeda, also is facing generic competition. In the respiratory area with inhalers, it’s tough to get drugs approved, so the competition comes slowly,” he said.

Management 105

Management Manufacturing Sales Competition 105

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn. This strategy is often chosen by the brand manufacturers who offer higher rebates at the net price level in exchange for better placement on formularies. The current U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97

PM360

SEPTEMBER 28, 2022

PM360 spoke to Kokino about the evolution of the biosimilars market from its nascent days, why the now increased competition within the market is causing some companies to reconsider developing biosimilars, what to look for over the next few years, and how Accord’s approach is a bit different from what other companies are doing.

Competition 98

Competition Marketing Biopharma Manufacturing 98

Pharma Pathway

NOVEMBER 28, 2022

Emcure Pharmaceuticals, We are a fast-growing Indian Pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends and unparalleled competitive advantage establishing its presence in all major therapies in the domestic market.

Engineering 76

Engineering Pharmaceutical Competition Training 76

Rep-Lite

MARCH 14, 2024

Medical sales representatives are the medium through which medical companies sell their healthcare products to providers like hospitals and clinics. They build relationships, understand needs, and offer tailored solutions to these healthcare providers. Contact Rep-Lite For Unmatched Talent Management!

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

European Pharmaceutical Review

NOVEMBER 8, 2022

The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 3) policing anticompetitive settlements between competing drug manufacturers. 3) policing anticompetitive settlements between competing drug manufacturers. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Scott’s Directories

AUGUST 2, 2023

The competitive healthcare landscape has access to accurate and comprehensive information, which is crucial for businesses looking to connect with medical professionals. Research and Analysis: Whether in academia or the healthcare industry, having a reliable source of information can make all the difference.

Physicians 40

Physicians Prospecting Sales Doctors 40

Healthcare Success

MAY 9, 2022

We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . History of QR Codes in Healthcare Marketing .

Leads 112

Leads Patients Healthcare Provider Healthcare 112

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. AbbVie had reached settlement agreements with the biosimilar manufacturers to keep the biosimilars off the US market until 2023. Many other biosimilars have also been FDA-approved since 2016.

Competition 59

Competition Marketing FDA Physicians 59

Medico Reach

OCTOBER 17, 2022

What really matters are the orthopedic medical device trends that are already shaping the healthcare industry. Advancements in medical technology will always be a favorite topic of discussion when analyzing the healthcare sector. Healthcare executives are also looking into AR spinal surgical systems. Let’s dive right in!

Medical 98

Medical Food and Drug Administration Healthcare Healthcare 98

Curzon Consulting

JULY 24, 2023

He is particularly interested and enjoys opportunities that are complex, challenging and often breaking new ground for an organisation so that they can benefit from his rigorous and methodical approach that delivers increased competitive advantage, risk management and ensure regulatory compliance.

Consulting 52

Consulting Management Competition Manufacturing 52

Scott’s Directories

JUNE 8, 2023

In today’s competitive healthcare industry, effective marketing strategies are essential for businesses looking to thrive and succeed. B2B medical marketing, in particular, requires a unique approach that targets healthcare professionals and organizations. Here are some strategies to consider: a.

Medical 52

Medical Marketing Doctors Physicians 52